Sigyn Therapeutics, Inc. (SIGY)
OTCMKTS · Delayed Price · Currency is USD
0.7499
+0.1350 (21.95%)
At close: Feb 3, 2026
Sigyn Therapeutics Market Cap
Sigyn Therapeutics has a market cap or net worth of $1.2 million as of February 12, 2026. Its market cap has decreased by -95.90% in one year.
Market Cap
1.20M
Enterprise Value
3.93M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.75
Market Cap Chart
Since October 20, 2020, Sigyn Therapeutics's market cap has decreased from 66.98M to 1.20M, a decrease of -98.20%. That is a compound annual growth rate of -53.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 1.20M | -56.14% |
| Dec 16, 2025 | 2.75M | -45.72% |
| Dec 17, 2024 | 5.06M | -16.78% |
| Dec 27, 2023 | 6.08M | -4.15% |
| Dec 29, 2022 | 6.34M | -66.00% |
| Dec 30, 2021 | 18.65M | -57.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agentix | 1.68M |
| Carisma Therapeutics | 1.63M |
| Orgenesis | 1.57M |
| inTerra Resources | 1.49M |
| International Stem Cell | 1.32M |
| Halberd | 1.16M |
| Evofem Biosciences | 1.14M |
| CERo Therapeutics Holdings | 1.14M |